Caprock Group, Inc. Sera Prognostics, Inc. Transaction History
Caprock Group, Inc.
- $3.21 Billion
- Q1 2025
A detailed history of Caprock Group, Inc. transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 33,523 shares of SERA stock, worth $64,028. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,523Holding current value
$64,028% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SERA
# of Institutions
74Shares Held
22.6MCall Options Held
300Put Options Held
800-
Baker Bros. Advisors LP New York, NY5.5MShares$10.5 Million0.24% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$5.79 Million0.23% of portfolio
-
Interwest Venture Management CO2.42MShares$4.62 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$3.15 Million1.65% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$2.69 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $56.5M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...